Hybridoma technology
Hybridoma technology is a process used to produce specialized cells called monoclonal antibodies, which are useful in medicine and research. It involves fusing a specific type of immune cell (a B cell that produces antibodies) with a cancer cell. The resulting hybrid cell, called a hybridoma, can grow indefinitely and produces large amounts of the desired antibody. This technology allows scientists to create antibodies that are identical and target specific substances, making them valuable for diagnosing diseases, developing treatments, and conducting various research applications.
Additional Insights
-
Hybridoma technology is a laboratory method used to produce large quantities of specific antibodies. It combines two types of cells: one that produces a unique antibody and another that can grow indefinitely. These two cells are fused to create a hybrid cell, or hybridoma, which can both produce the desired antibody and multiply. This technology is crucial in medical research, diagnostics, and therapies, allowing for the creation of highly specific antibodies that can target diseases, such as cancer, effectively.